Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Arena Pharma 4Q loss narrows, research costs drop
Yahoo/AP
Friday, March 11, 2011 - 11:43am
tags:
Arena Pharmaceuticals, earnings
Dendreon wins FDA nod on production increase
Fierce Pharma
Friday, March 11, 2011 - 9:41am
tags:
FDA, Dendreon, Provenge, vaccines, prostate cancer
Pfizer/J&J Bapineuzumab Might Tackle Alzheimer’s Protein Early On
WSJ Online
Friday, March 11, 2011 - 9:12am
tags:
bapineuzumab, Pfizer, JNJ, Alzheimer's disease
Former KV Exec Pleads Guilty To Selling Big Pills
Pharmalot
Friday, March 11, 2011 - 8:56am
tags:
KV Pharmaceutical, morphine sulfate, Marc Hermelin
Sanofi, Regeneron Lung Cancer Therapy Fails in Late Study
Bloomberg
Thursday, March 10, 2011 - 9:45pm
tags:
lung cancer, Regeneron, Aflibercept, Sanofi
Aryx Therapeutics, hurt by FDA delay, plans to shut down
Bizjournals.com
Thursday, March 10, 2011 - 9:43pm
tags:
ARYx, FDA, naronapride
Zeltia Fails to Win U.K. Backing for Ovarian Cancer Treatment
Bloomberg
Thursday, March 10, 2011 - 9:40pm
tags:
Zeltia, UK, ovarian cancer
Vertex epilepsy drug meets key midstage study goal
Yahoo/AP
Thursday, March 10, 2011 - 6:02pm
tags:
epilepsy, Vertex Pharmaceuticals, VX-765
J&J Unit Signs Consent Decree With U.S. FDA Over 3 Plants
Bloomberg
Thursday, March 10, 2011 - 5:55pm
tags:
JNJ, recalls, consent decree, FDA
Will Celgene Earn or Burn?
Motley Fool
Thursday, March 10, 2011 - 5:54pm
tags:
Celgene
AstraZeneca to Pay $68.5 Million to States Over Seroquel
Bloomberg
Thursday, March 10, 2011 - 12:15pm
tags:
AstraZeneca, Seroquel, settlements
Epizyme snags $206M epigenetics deal with Eisai
Fierce Biotech
Thursday, March 10, 2011 - 12:03pm
tags:
Eisai, Epizyme, epigenetics
Actelion On The Defensive: Corporate Governance White Paper
InVivo
Thursday, March 10, 2011 - 12:02pm
tags:
Actelion
Spectrum Pharmaceuticals 4Q profit falls 56 pct
Yahoo/AP
Thursday, March 10, 2011 - 11:08am
tags:
earnings, Spectrum Pharmaceuticals
KV's Makena delivers $1,500 sticker shock to docs
Fierce Pharma
Thursday, March 10, 2011 - 10:58am
tags:
KV Pharmaceutical, Makena, premature birth
Osiris Profits Rise on Lower Costs
Yahoo/Zacks.com
Thursday, March 10, 2011 - 10:36am
tags:
earnings, Osiris, Genzyme
WuXi PharmaTech on the Right Track With 24% Growth in Revenues
Seeking Alpha
Thursday, March 10, 2011 - 10:35am
tags:
WuXi PharmaTech, China
Exelixis plans $165M stock sale
Bizjournals.com
Thursday, March 10, 2011 - 10:23am
tags:
Exelixis, stock offering
The New Lupus Drug: What The Wags Are Saying
Pharmalot
Thursday, March 10, 2011 - 10:21am
tags:
lupus, Human Genome Sciences, Benlysta
Merck KGaA Seeks Fix for ‘Bunker’ Culture to Woo Investors
Bloomberg
Thursday, March 10, 2011 - 10:20am
tags:
Merck KGaA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.